Trial site
Velocity Clinical Research, Boise
- 6running trials
- 17closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Diabetic neuropathy3 trials
- Obesity2 trials
- Alopecia areata1 trial
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- Coeliac disease1 trial
- COPD1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 315 trials
- Phase 27 trials
- Phase 11 trial
- Status
- Completed16 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- ModernaTX, Inc.4 trials
- Vertex Pharmaceuticals Incorporated3 trials
- Amgen2 trials
- Cassava Sciences, Inc.2 trials
- BioNTech SE1 trial
- and 11 more
Running trials
Active, not recruiting
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic neuropathy1 recruiting
Closed trials
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Completed
Recruiting
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Completed
Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
Completed
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
Completed
Completed
Completed
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
Completed
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Completed
A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026